Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial

Correction to: Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in severely ill adults with COVID-19: A structured summary of a study protocol for a randomized controlled trial

An amendment to this paper has been published and can be accessed via the original article.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current controlled trials in cardiovascular medicine 2020-06, Vol.21 (1), p.536-536, Article 536
Hauptverfasser: Eckhardt, Christina M, Cummings, Matthew J, Rajagopalan, Kartik N, Borden, Sarah, Bitan, Zachary C, Wolf, Allison, Kantor, Alex, Briese, Thomas, Meyer, Benjamin J, Jacobson, Samuel D, Scotto, Dawn, Mishra, Nischay, Philip, Neena M, Stotler, Brie A, Schwartz, Joseph, Shaz, Beth, Spitalnik, Steven L, Eisenberger, Andrew, Hod, Eldad A, Justman, Jessica, Cheung, Ken, Lipkin, W Ian, O'Donnell, Max R
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:An amendment to this paper has been published and can be accessed via the original article.
ISSN:1745-6215
1745-6215
DOI:10.1186/s13063-020-04504-x